Iguratimod is effective in refractory rheumatoid arthritis patients with inadequate response to methotrexate-cyclosporin A-hydroxychloroquine-prednisone.
作者信息
Zheng N, Guo C, Wu R
机构信息
a Department of Rheumatology and Immunology , The First Affiliated Hospital of Nanchang University , Nanchang , PR China.
出版信息
Scand J Rheumatol. 2018 Sep;47(5):422-424. doi: 10.1080/03009742.2017.1376109. Epub 2018 Jan 10.
Abstract
摘要
Zotero 插件